Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40,762,262
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
21,603,795
-
Shares change
-
+3,197,108
-
Total reported value, excl. options
-
$988,158,909
-
Value change
-
+$115,760,338
-
Number of buys
-
67
-
Number of sells
-
-47
-
Price
-
$45.74
Significant Holders of Pulmonx Corp - COM (LUNG) as of Q1 2021
131 filings reported holding LUNG - Pulmonx Corp - COM as of Q1 2021.
Pulmonx Corp - COM (LUNG) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21,603,795 shares
of 40,762,262 outstanding shares and own 53% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (1,192,000 shares), VANGUARD GROUP INC (1,141,640 shares), RTW INVESTMENTS, LP (1,129,600 shares), Capital World Investors (1,060,000 shares), GILDER GAGNON HOWE & CO LLC (1,048,321 shares), KPCB XIII Associates, LLC (994,971 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (937,032 shares), BlackRock Inc. (916,921 shares), ABG Innovation Capital Partners III GP Ltd (833,333 shares), and ABG-WTT Global Life Science Capital Partners GP Ltd (815,019 shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.